4 ms·
Speaking as an enthusiast, it does seem like there will be a shift from certain drugs being manufactured by a pharmaceuticals producer to self-manufacture from
by taylorportman 5y ago
Speaking as an enthusiast, it does seem like there will be a shift from certain drugs being manufactured by a pharmaceuticals producer to self-manufacture from mRNA sequence delivery. I wonder what it means for pharmaceutical companies that have IP for, say insulin, but someone else claims control of the mRNA code that triggers it's production?
- benglish11 5y agoThat may be a bad example but the “patents on insulin” are on the specific processes to create it not on insulin itself. This would be another unique process.